Stopain Clinical Offers Anti-Opioid Headache Pain Relief
Troy Healthcare launches Stopain Clinical Migraine & Headache, formulated without acetaminophen, aspirin, caffeine or other NSAIDs as a pain-relief alternative to potentially addictive opioids.
The launch of the product comes at a time when frequency of migraines is estimated to be on the rise due to increased stress from pandemic-related economic hardships and COVID-19-associated headaches.
Troy Healthcare provides Stopain Clinical, a topical analgesic offered by physical therapists and others to help those suffering from arthritis, chronic pain, back aches or sprains. The active ingredients in Stopain Clinical Migraine & Headache are formulated to help reduce the symptoms typically associated with migraines, including pain in the front and back of the head, as well as help control nausea and sickness.
Troy Healthcare Launches Effective, Topical Migraine & Headache Product
Share Article
Offering an alternative to potentially addictive opioids, Stopain® Clinical Migraine & Headache is proven to provide safe and effective pain relief.
We’re proud to offer a topical solution that is safe and effective in relieving migraines and headaches during any stage of progression. HAZLETON, Pa. (PRWEB) January 21, 2021 An estimated 39 million individuals suffer from migraines in the United States alone. Troy Healthcare’s latest product Stopain® Clinical Migraine & Headache is formulated to provide immediate and safe pain relief. This topical treatment does not include acetaminophen, aspirin, caffeine or other NSAIDs and offers an effective alternative to potentially addictive opioids. The launch of the product comes at a time where frequency of migraines is on the rise due to increased stress from pandemic related eco